0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IL-23 Receptor Antagonist Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-19N18137
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global IL 23 Receptor Antagonist Market Research Report 2024
BUY CHAPTERS

Global IL-23 Receptor Antagonist Market Research Report 2024

Code: QYRE-Auto-19N18137
Report
August 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

IL-23 Receptor Antagonist Market

IL-23 receptor antagonists are a class of biologic drugs that target the IL-23 pathway,specifically by blocking the IL-23 receptor.By inhibiting the IL-23 receptor,these antagonists disrupt the signaling cascade that leads to the production of pro-inflammatory cytokines,which are implicated in the chronic inflammation characteristic of these conditions.
The global IL-23 Receptor Antagonist market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for IL-23 Receptor Antagonist is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for IL-23 Receptor Antagonist is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of IL-23 Receptor Antagonist include Janssen Pharmaceuticals, Sun Pharma, Almirall, China Medical System, AbbVie Biotechnology, Eli Lilly, Teva, Amgen, Samsung Bioepis, Sandoz, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for IL-23 Receptor Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IL-23 Receptor Antagonist.
The IL-23 Receptor Antagonist market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global IL-23 Receptor Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IL-23 Receptor Antagonist manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of IL-23 Receptor Antagonist Market Report

Report Metric Details
Report Name IL-23 Receptor Antagonist Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Janssen Pharmaceuticals, Sun Pharma, Almirall, China Medical System, AbbVie Biotechnology, Eli Lilly, Teva, Amgen, Samsung Bioepis, Sandoz, Biocon Biologics, Celltrion, Qyuns Therapeutics, Bio-Thera Solutions, Huadong Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of IL-23 Receptor Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of IL-23 Receptor Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the IL-23 Receptor Antagonist Market report?

Ans: The main players in the IL-23 Receptor Antagonist Market are Janssen Pharmaceuticals, Sun Pharma, Almirall, China Medical System, AbbVie Biotechnology, Eli Lilly, Teva, Amgen, Samsung Bioepis, Sandoz, Biocon Biologics, Celltrion, Qyuns Therapeutics, Bio-Thera Solutions, Huadong Medicine

What are the Application segmentation covered in the IL-23 Receptor Antagonist Market report?

Ans: The Applications covered in the IL-23 Receptor Antagonist Market report are Crohn's Disease, Plaque Psoriasis, Psoriatic Arthritis, Other

What are the Type segmentation covered in the IL-23 Receptor Antagonist Market report?

Ans: The Types covered in the IL-23 Receptor Antagonist Market report are Ustekinumab, Briakinumab, Tildrakizumab, Guselkumab, Risankizumab, Mirikizumab, Other

Recommended Reports

Autoimmune Diseases

Diagnostics & Therapeutics

Receptor & Cell Therapy

1 IL-23 Receptor Antagonist Market Overview
1.1 Product Definition
1.2 IL-23 Receptor Antagonist by Type
1.2.1 Global IL-23 Receptor Antagonist Market Value Comparison by Type (2024-2030)
1.2.2 Ustekinumab
1.2.3 Briakinumab
1.2.4 Tildrakizumab
1.2.5 Guselkumab
1.2.6 Risankizumab
1.2.7 Mirikizumab
1.2.8 Other
1.3 IL-23 Receptor Antagonist by Application
1.3.1 Global IL-23 Receptor Antagonist Market Value by Application (2024-2030)
1.3.2 Crohn's Disease
1.3.3 Plaque Psoriasis
1.3.4 Psoriatic Arthritis
1.3.5 Other
1.4 Global IL-23 Receptor Antagonist Market Size Estimates and Forecasts
1.4.1 Global IL-23 Receptor Antagonist Revenue 2019-2030
1.4.2 Global IL-23 Receptor Antagonist Sales 2019-2030
1.4.3 Global IL-23 Receptor Antagonist Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 IL-23 Receptor Antagonist Market Competition by Manufacturers
2.1 Global IL-23 Receptor Antagonist Sales Market Share by Manufacturers (2019-2024)
2.2 Global IL-23 Receptor Antagonist Revenue Market Share by Manufacturers (2019-2024)
2.3 Global IL-23 Receptor Antagonist Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of IL-23 Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IL-23 Receptor Antagonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IL-23 Receptor Antagonist, Product Type & Application
2.7 Global Key Manufacturers of IL-23 Receptor Antagonist, Date of Enter into This Industry
2.8 Global IL-23 Receptor Antagonist Market Competitive Situation and Trends
2.8.1 Global IL-23 Receptor Antagonist Market Concentration Rate
2.8.2 The Global 5 and 10 Largest IL-23 Receptor Antagonist Players Market Share by Revenue
2.8.3 Global IL-23 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IL-23 Receptor Antagonist Market Scenario by Region
3.1 Global IL-23 Receptor Antagonist Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global IL-23 Receptor Antagonist Sales by Region: 2019-2030
3.2.1 Global IL-23 Receptor Antagonist Sales by Region: 2019-2024
3.2.2 Global IL-23 Receptor Antagonist Sales by Region: 2025-2030
3.3 Global IL-23 Receptor Antagonist Revenue by Region: 2019-2030
3.3.1 Global IL-23 Receptor Antagonist Revenue by Region: 2019-2024
3.3.2 Global IL-23 Receptor Antagonist Revenue by Region: 2025-2030
3.4 North America IL-23 Receptor Antagonist Market Facts & Figures by Country
3.4.1 North America IL-23 Receptor Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America IL-23 Receptor Antagonist Sales by Country (2019-2030)
3.4.3 North America IL-23 Receptor Antagonist Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe IL-23 Receptor Antagonist Market Facts & Figures by Country
3.5.1 Europe IL-23 Receptor Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe IL-23 Receptor Antagonist Sales by Country (2019-2030)
3.5.3 Europe IL-23 Receptor Antagonist Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IL-23 Receptor Antagonist Market Facts & Figures by Region
3.6.1 Asia Pacific IL-23 Receptor Antagonist Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific IL-23 Receptor Antagonist Sales by Region (2019-2030)
3.6.3 Asia Pacific IL-23 Receptor Antagonist Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IL-23 Receptor Antagonist Market Facts & Figures by Country
3.7.1 Latin America IL-23 Receptor Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America IL-23 Receptor Antagonist Sales by Country (2019-2030)
3.7.3 Latin America IL-23 Receptor Antagonist Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IL-23 Receptor Antagonist Market Facts & Figures by Country
3.8.1 Middle East and Africa IL-23 Receptor Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa IL-23 Receptor Antagonist Sales by Country (2019-2030)
3.8.3 Middle East and Africa IL-23 Receptor Antagonist Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IL-23 Receptor Antagonist Sales by Type (2019-2030)
4.1.1 Global IL-23 Receptor Antagonist Sales by Type (2019-2024)
4.1.2 Global IL-23 Receptor Antagonist Sales by Type (2025-2030)
4.1.3 Global IL-23 Receptor Antagonist Sales Market Share by Type (2019-2030)
4.2 Global IL-23 Receptor Antagonist Revenue by Type (2019-2030)
4.2.1 Global IL-23 Receptor Antagonist Revenue by Type (2019-2024)
4.2.2 Global IL-23 Receptor Antagonist Revenue by Type (2025-2030)
4.2.3 Global IL-23 Receptor Antagonist Revenue Market Share by Type (2019-2030)
4.3 Global IL-23 Receptor Antagonist Price by Type (2019-2030)
5 Segment by Application
5.1 Global IL-23 Receptor Antagonist Sales by Application (2019-2030)
5.1.1 Global IL-23 Receptor Antagonist Sales by Application (2019-2024)
5.1.2 Global IL-23 Receptor Antagonist Sales by Application (2025-2030)
5.1.3 Global IL-23 Receptor Antagonist Sales Market Share by Application (2019-2030)
5.2 Global IL-23 Receptor Antagonist Revenue by Application (2019-2030)
5.2.1 Global IL-23 Receptor Antagonist Revenue by Application (2019-2024)
5.2.2 Global IL-23 Receptor Antagonist Revenue by Application (2025-2030)
5.2.3 Global IL-23 Receptor Antagonist Revenue Market Share by Application (2019-2030)
5.3 Global IL-23 Receptor Antagonist Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Janssen Pharmaceuticals
6.1.1 Janssen Pharmaceuticals Company Information
6.1.2 Janssen Pharmaceuticals Description and Business Overview
6.1.3 Janssen Pharmaceuticals IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Janssen Pharmaceuticals IL-23 Receptor Antagonist Product Portfolio
6.1.5 Janssen Pharmaceuticals Recent Developments/Updates
6.2 Sun Pharma
6.2.1 Sun Pharma Company Information
6.2.2 Sun Pharma Description and Business Overview
6.2.3 Sun Pharma IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sun Pharma IL-23 Receptor Antagonist Product Portfolio
6.2.5 Sun Pharma Recent Developments/Updates
6.3 Almirall
6.3.1 Almirall Company Information
6.3.2 Almirall Description and Business Overview
6.3.3 Almirall IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Almirall IL-23 Receptor Antagonist Product Portfolio
6.3.5 Almirall Recent Developments/Updates
6.4 China Medical System
6.4.1 China Medical System Company Information
6.4.2 China Medical System Description and Business Overview
6.4.3 China Medical System IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China Medical System IL-23 Receptor Antagonist Product Portfolio
6.4.5 China Medical System Recent Developments/Updates
6.5 AbbVie Biotechnology
6.5.1 AbbVie Biotechnology Company Information
6.5.2 AbbVie Biotechnology Description and Business Overview
6.5.3 AbbVie Biotechnology IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Biotechnology IL-23 Receptor Antagonist Product Portfolio
6.5.5 AbbVie Biotechnology Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eli Lilly IL-23 Receptor Antagonist Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Teva
6.7.1 Teva Company Information
6.7.2 Teva Description and Business Overview
6.7.3 Teva IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Teva IL-23 Receptor Antagonist Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Company Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amgen IL-23 Receptor Antagonist Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 Samsung Bioepis
6.9.1 Samsung Bioepis Company Information
6.9.2 Samsung Bioepis Description and Business Overview
6.9.3 Samsung Bioepis IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Samsung Bioepis IL-23 Receptor Antagonist Product Portfolio
6.9.5 Samsung Bioepis Recent Developments/Updates
6.10 Sandoz
6.10.1 Sandoz Company Information
6.10.2 Sandoz Description and Business Overview
6.10.3 Sandoz IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sandoz IL-23 Receptor Antagonist Product Portfolio
6.10.5 Sandoz Recent Developments/Updates
6.11 Biocon Biologics
6.11.1 Biocon Biologics Company Information
6.11.2 Biocon Biologics Description and Business Overview
6.11.3 Biocon Biologics IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biocon Biologics IL-23 Receptor Antagonist Product Portfolio
6.11.5 Biocon Biologics Recent Developments/Updates
6.12 Celltrion
6.12.1 Celltrion Company Information
6.12.2 Celltrion Description and Business Overview
6.12.3 Celltrion IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Celltrion IL-23 Receptor Antagonist Product Portfolio
6.12.5 Celltrion Recent Developments/Updates
6.13 Qyuns Therapeutics
6.13.1 Qyuns Therapeutics Company Information
6.13.2 Qyuns Therapeutics Description and Business Overview
6.13.3 Qyuns Therapeutics IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Qyuns Therapeutics IL-23 Receptor Antagonist Product Portfolio
6.13.5 Qyuns Therapeutics Recent Developments/Updates
6.14 Bio-Thera Solutions
6.14.1 Bio-Thera Solutions Company Information
6.14.2 Bio-Thera Solutions Description and Business Overview
6.14.3 Bio-Thera Solutions IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bio-Thera Solutions IL-23 Receptor Antagonist Product Portfolio
6.14.5 Bio-Thera Solutions Recent Developments/Updates
6.15 Huadong Medicine
6.15.1 Huadong Medicine Company Information
6.15.2 Huadong Medicine Description and Business Overview
6.15.3 Huadong Medicine IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Huadong Medicine IL-23 Receptor Antagonist Product Portfolio
6.15.5 Huadong Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IL-23 Receptor Antagonist Industry Chain Analysis
7.2 IL-23 Receptor Antagonist Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IL-23 Receptor Antagonist Production Mode & Process
7.4 IL-23 Receptor Antagonist Sales and Marketing
7.4.1 IL-23 Receptor Antagonist Sales Channels
7.4.2 IL-23 Receptor Antagonist Distributors
7.5 IL-23 Receptor Antagonist Customers
8 IL-23 Receptor Antagonist Market Dynamics
8.1 IL-23 Receptor Antagonist Industry Trends
8.2 IL-23 Receptor Antagonist Market Drivers
8.3 IL-23 Receptor Antagonist Market Challenges
8.4 IL-23 Receptor Antagonist Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global IL-23 Receptor Antagonist Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global IL-23 Receptor Antagonist Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global IL-23 Receptor Antagonist Market Competitive Situation by Manufacturers in 2023
 Table 4. Global IL-23 Receptor Antagonist Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global IL-23 Receptor Antagonist Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global IL-23 Receptor Antagonist Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global IL-23 Receptor Antagonist Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market IL-23 Receptor Antagonist Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of IL-23 Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of IL-23 Receptor Antagonist, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of IL-23 Receptor Antagonist, Product Type & Application
 Table 12. Global Key Manufacturers of IL-23 Receptor Antagonist, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IL-23 Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IL-23 Receptor Antagonist as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IL-23 Receptor Antagonist Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global IL-23 Receptor Antagonist Sales by Region (2019-2024) & (K Units)
 Table 18. Global IL-23 Receptor Antagonist Sales Market Share by Region (2019-2024)
 Table 19. Global IL-23 Receptor Antagonist Sales by Region (2025-2030) & (K Units)
 Table 20. Global IL-23 Receptor Antagonist Sales Market Share by Region (2025-2030)
 Table 21. Global IL-23 Receptor Antagonist Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global IL-23 Receptor Antagonist Revenue Market Share by Region (2019-2024)
 Table 23. Global IL-23 Receptor Antagonist Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global IL-23 Receptor Antagonist Revenue Market Share by Region (2025-2030)
 Table 25. North America IL-23 Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America IL-23 Receptor Antagonist Sales by Country (2019-2024) & (K Units)
 Table 27. North America IL-23 Receptor Antagonist Sales by Country (2025-2030) & (K Units)
 Table 28. North America IL-23 Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America IL-23 Receptor Antagonist Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe IL-23 Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe IL-23 Receptor Antagonist Sales by Country (2019-2024) & (K Units)
 Table 32. Europe IL-23 Receptor Antagonist Sales by Country (2025-2030) & (K Units)
 Table 33. Europe IL-23 Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe IL-23 Receptor Antagonist Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific IL-23 Receptor Antagonist Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific IL-23 Receptor Antagonist Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific IL-23 Receptor Antagonist Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific IL-23 Receptor Antagonist Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific IL-23 Receptor Antagonist Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America IL-23 Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America IL-23 Receptor Antagonist Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America IL-23 Receptor Antagonist Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America IL-23 Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America IL-23 Receptor Antagonist Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa IL-23 Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa IL-23 Receptor Antagonist Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa IL-23 Receptor Antagonist Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa IL-23 Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa IL-23 Receptor Antagonist Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global IL-23 Receptor Antagonist Sales (K Units) by Type (2019-2024)
 Table 51. Global IL-23 Receptor Antagonist Sales (K Units) by Type (2025-2030)
 Table 52. Global IL-23 Receptor Antagonist Sales Market Share by Type (2019-2024)
 Table 53. Global IL-23 Receptor Antagonist Sales Market Share by Type (2025-2030)
 Table 54. Global IL-23 Receptor Antagonist Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global IL-23 Receptor Antagonist Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global IL-23 Receptor Antagonist Revenue Market Share by Type (2019-2024)
 Table 57. Global IL-23 Receptor Antagonist Revenue Market Share by Type (2025-2030)
 Table 58. Global IL-23 Receptor Antagonist Price (US$/Unit) by Type (2019-2024)
 Table 59. Global IL-23 Receptor Antagonist Price (US$/Unit) by Type (2025-2030)
 Table 60. Global IL-23 Receptor Antagonist Sales (K Units) by Application (2019-2024)
 Table 61. Global IL-23 Receptor Antagonist Sales (K Units) by Application (2025-2030)
 Table 62. Global IL-23 Receptor Antagonist Sales Market Share by Application (2019-2024)
 Table 63. Global IL-23 Receptor Antagonist Sales Market Share by Application (2025-2030)
 Table 64. Global IL-23 Receptor Antagonist Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global IL-23 Receptor Antagonist Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global IL-23 Receptor Antagonist Revenue Market Share by Application (2019-2024)
 Table 67. Global IL-23 Receptor Antagonist Revenue Market Share by Application (2025-2030)
 Table 68. Global IL-23 Receptor Antagonist Price (US$/Unit) by Application (2019-2024)
 Table 69. Global IL-23 Receptor Antagonist Price (US$/Unit) by Application (2025-2030)
 Table 70. Janssen Pharmaceuticals Company Information
 Table 71. Janssen Pharmaceuticals Description and Business Overview
 Table 72. Janssen Pharmaceuticals IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Janssen Pharmaceuticals IL-23 Receptor Antagonist Product
 Table 74. Janssen Pharmaceuticals Recent Developments/Updates
 Table 75. Sun Pharma Company Information
 Table 76. Sun Pharma Description and Business Overview
 Table 77. Sun Pharma IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Sun Pharma IL-23 Receptor Antagonist Product
 Table 79. Sun Pharma Recent Developments/Updates
 Table 80. Almirall Company Information
 Table 81. Almirall Description and Business Overview
 Table 82. Almirall IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Almirall IL-23 Receptor Antagonist Product
 Table 84. Almirall Recent Developments/Updates
 Table 85. China Medical System Company Information
 Table 86. China Medical System Description and Business Overview
 Table 87. China Medical System IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. China Medical System IL-23 Receptor Antagonist Product
 Table 89. China Medical System Recent Developments/Updates
 Table 90. AbbVie Biotechnology Company Information
 Table 91. AbbVie Biotechnology Description and Business Overview
 Table 92. AbbVie Biotechnology IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. AbbVie Biotechnology IL-23 Receptor Antagonist Product
 Table 94. AbbVie Biotechnology Recent Developments/Updates
 Table 95. Eli Lilly Company Information
 Table 96. Eli Lilly Description and Business Overview
 Table 97. Eli Lilly IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Eli Lilly IL-23 Receptor Antagonist Product
 Table 99. Eli Lilly Recent Developments/Updates
 Table 100. Teva Company Information
 Table 101. Teva Description and Business Overview
 Table 102. Teva IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Teva IL-23 Receptor Antagonist Product
 Table 104. Teva Recent Developments/Updates
 Table 105. Amgen Company Information
 Table 106. Amgen Description and Business Overview
 Table 107. Amgen IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Amgen IL-23 Receptor Antagonist Product
 Table 109. Amgen Recent Developments/Updates
 Table 110. Samsung Bioepis Company Information
 Table 111. Samsung Bioepis Description and Business Overview
 Table 112. Samsung Bioepis IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Samsung Bioepis IL-23 Receptor Antagonist Product
 Table 114. Samsung Bioepis Recent Developments/Updates
 Table 115. Sandoz Company Information
 Table 116. Sandoz Description and Business Overview
 Table 117. Sandoz IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Sandoz IL-23 Receptor Antagonist Product
 Table 119. Sandoz Recent Developments/Updates
 Table 120. Biocon Biologics Company Information
 Table 121. Biocon Biologics Description and Business Overview
 Table 122. Biocon Biologics IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Biocon Biologics IL-23 Receptor Antagonist Product
 Table 124. Biocon Biologics Recent Developments/Updates
 Table 125. Celltrion Company Information
 Table 126. Celltrion Description and Business Overview
 Table 127. Celltrion IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Celltrion IL-23 Receptor Antagonist Product
 Table 129. Celltrion Recent Developments/Updates
 Table 130. Qyuns Therapeutics Company Information
 Table 131. Qyuns Therapeutics Description and Business Overview
 Table 132. Qyuns Therapeutics IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Qyuns Therapeutics IL-23 Receptor Antagonist Product
 Table 134. Qyuns Therapeutics Recent Developments/Updates
 Table 135. Bio-Thera Solutions Company Information
 Table 136. Bio-Thera Solutions Description and Business Overview
 Table 137. Bio-Thera Solutions IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Bio-Thera Solutions IL-23 Receptor Antagonist Product
 Table 139. Bio-Thera Solutions Recent Developments/Updates
 Table 140. Huadong Medicine Company Information
 Table 141. Huadong Medicine Description and Business Overview
 Table 142. Huadong Medicine IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Huadong Medicine IL-23 Receptor Antagonist Product
 Table 144. Huadong Medicine Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. IL-23 Receptor Antagonist Distributors List
 Table 148. IL-23 Receptor Antagonist Customers List
 Table 149. IL-23 Receptor Antagonist Market Trends
 Table 150. IL-23 Receptor Antagonist Market Drivers
 Table 151. IL-23 Receptor Antagonist Market Challenges
 Table 152. IL-23 Receptor Antagonist Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IL-23 Receptor Antagonist
 Figure 2. Global IL-23 Receptor Antagonist Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global IL-23 Receptor Antagonist Market Share by Type: 2023 & 2030
 Figure 4. Ustekinumab Product Picture
 Figure 5. Briakinumab Product Picture
 Figure 6. Tildrakizumab Product Picture
 Figure 7. Guselkumab Product Picture
 Figure 8. Risankizumab Product Picture
 Figure 9. Mirikizumab Product Picture
 Figure 10. Other Product Picture
 Figure 11. Global IL-23 Receptor Antagonist Market Value by Application (2024-2030) & (US$ Million)
 Figure 12. Global IL-23 Receptor Antagonist Market Share by Application: 2023 & 2030
 Figure 13. Crohn's Disease
 Figure 14. Plaque Psoriasis
 Figure 15. Psoriatic Arthritis
 Figure 16. Other
 Figure 17. Global IL-23 Receptor Antagonist Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 18. Global IL-23 Receptor Antagonist Market Size (2019-2030) & (US$ Million)
 Figure 19. Global IL-23 Receptor Antagonist Sales (2019-2030) & (K Units)
 Figure 20. Global IL-23 Receptor Antagonist Average Price (US$/Unit) & (2019-2030)
 Figure 21. IL-23 Receptor Antagonist Report Years Considered
 Figure 22. IL-23 Receptor Antagonist Sales Share by Manufacturers in 2023
 Figure 23. Global IL-23 Receptor Antagonist Revenue Share by Manufacturers in 2023
 Figure 24. Global 5 and 10 Largest IL-23 Receptor Antagonist Players: Market Share by Revenue in IL-23 Receptor Antagonist in 2023
 Figure 25. IL-23 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 26. Global IL-23 Receptor Antagonist Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 27. North America IL-23 Receptor Antagonist Sales Market Share by Country (2019-2030)
 Figure 28. North America IL-23 Receptor Antagonist Revenue Market Share by Country (2019-2030)
 Figure 29. United States IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Canada IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Europe IL-23 Receptor Antagonist Sales Market Share by Country (2019-2030)
 Figure 32. Europe IL-23 Receptor Antagonist Revenue Market Share by Country (2019-2030)
 Figure 33. Germany IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. France IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. U.K. IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Italy IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Russia IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Asia Pacific IL-23 Receptor Antagonist Sales Market Share by Region (2019-2030)
 Figure 39. Asia Pacific IL-23 Receptor Antagonist Revenue Market Share by Region (2019-2030)
 Figure 40. China IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Japan IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. South Korea IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. India IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Australia IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. China Taiwan IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Southeast Asia IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Latin America IL-23 Receptor Antagonist Sales Market Share by Country (2019-2030)
 Figure 48. Mexico IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Brazil IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Argentina IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Colombia IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Middle East and Africa IL-23 Receptor Antagonist Sales Market Share by Country (2019-2030)
 Figure 53. Middle East and Africa IL-23 Receptor Antagonist Revenue Market Share by Country (2019-2030)
 Figure 54. Turkey IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Saudi Arabia IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. UAE IL-23 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 57. Global Sales Market Share of IL-23 Receptor Antagonist by Type (2019-2030)
 Figure 58. Global Revenue Market Share of IL-23 Receptor Antagonist by Type (2019-2030)
 Figure 59. Global IL-23 Receptor Antagonist Price (US$/Unit) by Type (2019-2030)
 Figure 60. Global Sales Market Share of IL-23 Receptor Antagonist by Application (2019-2030)
 Figure 61. Global Revenue Market Share of IL-23 Receptor Antagonist by Application (2019-2030)
 Figure 62. Global IL-23 Receptor Antagonist Price (US$/Unit) by Application (2019-2030)
 Figure 63. IL-23 Receptor Antagonist Value Chain
 Figure 64. IL-23 Receptor Antagonist Production Process
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart